Funding
← Back to your selection

Farallon Capital Management

Activity from announced rounds

Activity in this selectionUnited States

Farallon Capital Management is the investment manager identified by Encoded Therapeutics and HiBob, with Farallon also used as a short name.

Recorded funding activity

Encoded develops precision gene therapies for neurological disorders. HiBob supplies the Bob people-management platform, while Mirador develops medicines for inflammatory and fibrotic diseases. Their financing events retain the same manager identity without collapsing individual funds.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$830M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series B1

By primary sector

Biotech3

By country

United States3

Rounds

3 in this selection
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Participant
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed